The Rise of PROTACs and Targeted Protein Degradation Technologies
Traditional drug discovery has largely been built around a simple principle: find a pocket on a disease-relevant protein, bind it with sufficient affinity, and block its function. That strategy has produced many successful medicines, but it also leaves numerous biologically important proteins difficult to address with conventional small molecules. Targeted protein degradation (TPD) offers a…

